Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial

Hormone and Metabolic Research

Volumn 49, Issue 11, 2017, Pages 886-891

  Roshanravan, Neda ^a   Mahdavi, Reza ^a   Alizadeh, Effat ^a   Jafarabadi, Mohammad Asghari ^b,c   Hedayati, Mehdi ^d   Ghavami, Abed ^a   Alipour, Shahriar ^e   Alamdari, Naimeh Mesri ^f   Barati, Meisam ^a   Ostadrahimi, Alireza ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes mellitus; dietary intake; glucagon like peptide 1; high performance inulin; lipid profile; sodium butyrate

Indexed keywords

BUTYRIC ACID; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; BUTYRIC ACID DERIVATIVE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BIOSYNTHESIS; BLOOD; DIETARY SUPPLEMENT; METABOLISM;

BLOOD GLUCOSE; BUTYRATES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INULIN; LIPIDS; MALE; MIDDLE AGED;

EID: 85030553177     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0043-119089     Document Type: Article

References (38)

1. Ruan Y. Sun J. He J. Chen F. Chen R. Chen H. Effect of probiotics on glycemic control: A systematic review and meta-analysis of randomized, controlled trials. PloS one: 2015; 10 e0132121
2. Wild S. Roglic G. Green A. Sicree R. King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care: 2004; 27 1047 1053
3. Melli L. do Carmo-Rodrigues M. Araújo-Filho H. Solé D. de Morais M. Intestinal microbiota and allergic diseases: A systematic review. Allergol Immunopathol: 2016; 44 177 188
4. Le Barz M. Anhê F. F. Varin T. V. Desjardins Y. Levy E. Roy D. Urdaci M. C. Marette A. Probiotics as complementary treatment for metabolic disorders. Diabetes metab J: 2015; 39 291 303
5. Ericsson A. C. Franklin C. L. Manipulating the gut microbiota: Methods and challenges. ILAR J: 2015; 56 205 217
6. Hill C. Guarner F. Reid G. Gibson G. R. Merenstein D. J. Pot B. Morelli L. Canani R. B. Flint H. J. Salminen S. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol: 2014; 11 506 514
7. Pineiro M. Asp N-G. Reid G. Macfarlane S. Morelli L. Brunser O. Tuohy K. FAO Technical meeting on prebiotics. J Clin Gastroenterol: 2008; 42 S156 S159
8. de Vrese M. Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol: 2008; 111 1 66
9. Kolida S. Meyer D. Gibson G. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr: 2007; 61 1189 1195
10. Flamm G. Glinsmann W. Kritchevsky D. Prosky L. Roberfroid M. Inulin and oligofructose as dietary fiber: A review of the evidence. Crit Rev Food Sci Nutr: 2001; 41 353 362
11. Kolida S. Gibson G. R. Prebiotic capacity of inulin-type fructans. J Nutr: 2007; 137 2503S 2506S
12. Schrezenmeir J. de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr: 2001; 73 361s 364s
13. Cummings J. Pomare E. Branch W. Naylor C. Macfarlane G. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut: 1987; 28 1221 1227
14. McIntyre A. Gibson P. Young G. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut: 1993; 34 386 391
15. Singh B. Halestrap A. P. Paraskeva C. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis: 1997; 18 1265 1270
16. Harig J. M. Soergel K. H. Komorowski R. A. Wood C. M. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med: 1989; 320 23 28
17. Gao Z. Yin J. Zhang J. Ward R. E. Martin R. J. Lefevre M. Cefalu W. T. Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes: 2009; 58 1509 1517
18. Ahmad M. Krishnan S. Ramakrishna B. Mathan M. Pulimood A. Murthy S. Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut: 2000; 46 493 499
19. Holst J. J. The physiology of glucagon-like peptide 1. Physiol Rev: 2007; 87 1409 1439
20. Sa'ad H. Peppelenbosch M. P. Roelofsen H. Vonk R. J. Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta: 2010; 1801 1175 1183
21. Hur K. Y. Lee M-S. Gut microbiota and metabolic disorders. Diabetes Metab J: 2015; 39 198 203
22. Association AD Diagnosis and classification of diabetes mellitus. Diabetes Care: 2010; 33 S62 S69
23. Dehghan P. Gargari B. P. Asgharijafarabadi M. Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: A randomized, placebo-controlled clinical trial. Health Promot Perspect: 2013; 3 55 63
24. Dewulf E. M. Cani P. D. Claus S. P. Fuentes S. Puylaert P. G. Neyrinck A. M. Bindels L. B. de Vos W. M. Gibson G. R. Thissen J-P. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut: 2013; 62 1112 1121
25. Guess N. D. Dornhorst A. Oliver N. Bell J. D. Thomas E. L. Frost G. S. A randomized controlled trial: The effect of inulin on weight management and ectopic fat in subjects with prediabetes. Nutr Metab: 2015; 12 36 46
26. Parnell J. A. Reimer R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr: 2009; 89 1751 1759
27. Dehghan P. Gargari B. P. Jafar-Abadi M. A. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial. Nutrition: 2014; 30 418 423
28. Fernandes R. do Rosario V. A. Mocellin M. C. Kuntz M. G. Trindade E. B. Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: A systematic review. Clin Nutr: 2016; 113 1 10
29. Morel F. B. Dai Q. Ni J. Thomas D. Parnet P. Fança-Berthon P. α-Galacto-oligosaccharides dose-dependently reduce appetite and decrease inflammation in overweight adults. J Nutr: 2015; 145 2052 2059
30. Säemann M. D. Böhmig G. A. Österreicher C. H. Burtscher H. Parolini O. Diakos C. Stöckl J. Hörl W. H. Zlabinger G. J. Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J: 2000; 14 2380 2382
31. Cordel S. Dupas B. Douillard J. Y. Meflah K. Interleukin-2/sodium butyrate treatment cures rats bearing liver tumors after acquired 5-fluorouracil resistance. Int J Cancer: 1998; 78 735 739
32. Krokowicz L. Stojcev Z. Kaczmarek B. F. Kociemba W. Kaczmarek E. Walkowiak J. Krokowicz P. Drews M. Banasiewicz T. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis-a prospective randomized study. Int J Colorectal Dis: 2014; 29 387 393
33. Canani R. B. Terrin G. Cirillo P. Castaldo G. Salvatore F. Cardillo G. Coruzzo A. Troncone R. Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology: 2004; 127 630 634
34. Wolever T. Brighenti F. Royall D. Jenkins A. L. Jenkins D. J. Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol: 1989; 84 1027 1033
35. Everard A. Belzer C. Geurts L. Ouwerkerk J. P. Druart C. Bindels L. B. Guiot Y. Derrien M. Muccioli G. G. Delzenne N. M. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA: 2013; 110 9066 9071
36. Everard A. Lazarevic V. Derrien M. Girard M. Muccioli G. G. Neyrinck A. M. Possemiers S. Van Holle A. François P. de Vos W. M. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes: 2011; 60 2775 2786
37. Kimura I. Ozawa K. Inoue D. Imamura T. Kimura K. Maeda T. Terasawa K. Kashihara D. Hirano K. Tani T. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun: 2013; 4 1829 1841
38. Causey J. L. Feirtag J. M. Gallaher D. D. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res: 2000; 20 191 201